AAAAAA
Results:
1-11
|
Results: 11
Authors:
Danesi, R
De Braud, F
Fogli, S
Di Paolo, A
Del Tacca, M
Citation: R. Danesi et al., Pharmacogenetic determinants of anti-cancer drug activity and toxicity, TRENDS PHAR, 22(8), 2001, pp. 420-426
Authors:
Fogli, S
Danesi, R
Braud, FD
Pas, TD
Curigliano, G
Giovannetti, E
Del Tacca, M
Citation: S. Fogli et al., Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer, ANN ONCOL, 12(11), 2001, pp. 1553-1559
Authors:
Conte, PF
Gennari, A
Donati, S
Salvadori, B
Baldini, E
Bengala, C
Pazzagli, I
Orlandini, C
Danesi, R
Fogli, S
Del Tacca, M
Citation: Pf. Conte et al., Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study, BREAST CANC, 68(2), 2001, pp. 171-179
Authors:
Macchia, M
Barontini, S
Bertini, S
Di Bussolo, V
Fogli, S
Giovannetti, E
Grossi, E
Minutolo, F
Danesi, R
Citation: M. Macchia et al., Design, synthesis, and characterization of the antitumor activity of novelceramide analogues, J MED CHEM, 44(23), 2001, pp. 3994-4000
Authors:
De Pas, T
de Braud, F
Danesi, R
Sessa, C
Catania, C
Curigliano, G
Fogli, S
del Tacca, M
Zampino, G
Sbanotto, A
Rocca, A
Cinieri, S
Marrocco, E
Milani, A
Goldhirsch, A
Citation: T. De Pas et al., Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 821-827
Authors:
Innocenti, F
Danesi, R
Favre, C
Nardi, M
Menconi, MC
Di Paolo, A
Bocci, G
Fogli, S
Barbara, C
Barachini, S
Casazza, G
Macchia, P
Del Tacca, M
Citation: F. Innocenti et al., Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: Implications for drug monitoring in children withacute lymphoblastic leukemia, THER DRUG M, 22(4), 2000, pp. 375-382
Authors:
Gennari, A
Donati, S
Danesi, R
Fogli, S
Orlandini, C
Del Tacca, M
Conte, PF
Citation: A. Gennari et al., The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer, SEMIN ONCOL, 27(1), 2000, pp. 14-19
Authors:
Di Paolo, A
Danesi, R
Nardini, D
Bocci, G
Innocenti, F
Fogli, S
Barachini, S
Marchetti, A
Bevilacqua, G
Del Tacca, M
Citation: A. Di Paolo et al., Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells, BR J CANC, 82(4), 2000, pp. 905-912
Authors:
Innocenti, F
Danesi, R
Bocci, G
Fogli, S
Di Paolo, A
Del Tacca, M
Citation: F. Innocenti et al., Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens, CANC CHEMOT, 43(2), 1999, pp. 133-140
Authors:
Fogli, S
Danesi, R
Innocenti, F
Di Paolo, A
Bocci, G
Barbara, C
Del Tacca, M
Citation: S. Fogli et al., An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma, THER DRUG M, 21(3), 1999, pp. 367-375
Authors:
Bocci, G
Danesi, R
Benelli, U
Innocenti, F
Di Paolo, A
Fogli, S
Del Tacca, M
Citation: G. Bocci et al., Inhibitory effect of suramin in rat models of angiogenesis in vitro and invivo, CANC CHEMOT, 43(3), 1998, pp. 205-212
Risultati:
1-11
|